X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761040
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761060
https://www.fda.gov/drugs/drug-approvals-and-databases/fda-approves-gemtuzumab-ozogamicin-cd33-positive-aml-pediatric-patients#:~:text=On%20June%2016%2C%202020%2C%20the,patients%201%20month%20and%20older.
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761060
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761060
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761040
http://www.fiercepharma.com/pharma/pfizer-faces-first-2017-patent-loss-as-pristiq-generics-crash-party
http://www.biopharma-reporter.com/Markets-Regulations/Pfizer-resubmits-US-and-EU-application-for-withdrawn-ADC-Mylotarg
http://www.forbes.com/sites/johnlamattina/2016/10/12/is-biopharma-productivity-in-a-sharp-decline/#36ba16d449d6
Market Place
Share 
